Hema Now: Episode 26: Highlights from the 2025 Meeting of the International Myeloma Society

This episode provides timely coverage of the 2025 Meeting of the International Myeloma Society (IMS). Claudio Cerchione highlights the most important developments from the Annual Meeting, offers his reflections on the evolving treatment landscape, and discusses the role of research and collaboration in moving closer to a cure for myeloma.

Timestamps 

00:00 – Introduction

02:08 – Reflections on his own career

04:20 – Claudio’s initial interest in the field

06:46 – Key takeaways from IMS 2025 Meeting

10:09 – Any potential gaps in coverage?

11:50 – How different patient groups are identified

13:30 – Minimal residual disease

16:15 – Impact of medical societies

20:24 – Translating new findings into clinical practice

23:44 – Improving the accessibility of treatments

26:45 – Claudio’s key takeaways from IMS 2025 Meeting

Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.